Literature DB >> 783219

Variations in the susceptibility of lactating and non-lactating bovine udders to infection when infused with Escherichia coli.

A J Bramley.   

Abstract

Small numbers of Escherichia coli were infused into both lactating and non-lactating udders. Twelve of the 17 lactating quarters infused became infected, and all 12 showed clinical symptoms of udder disease. The 5 lactating quarters which did not become infected all had pre-infusion somatic cell counts greater than 300000 cells/ml milk, whilst all the quarters which became infected had cell counts less than 300000 cells/ml milk. E. coli was subsequently recovered from only 6 of the 16 non-lactating quarters infused. In only 2 of these quarters did clinical infection follow, both quarters being in a cow infused 2 d before calving. The remaining 4 quarters from which E. coli was recovered were all negative within 5 d of infusion. These differences in susceptibility are discussed, particularly with reference to the frequent occurrence of coliform mastitis at and shortly after calving.

Entities:  

Mesh:

Year:  1976        PMID: 783219     DOI: 10.1017/s0022029900015752

Source DB:  PubMed          Journal:  J Dairy Res        ISSN: 0022-0299            Impact factor:   1.904


  16 in total

1.  Differential induction of complement fragment C5a and inflammatory cytokines during intramammary infections with Escherichia coli and Staphylococcus aureus.

Authors:  C Riollet; P Rainard; B Poutrel
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

2.  Genome analysis of bovine-mastitis-associated Escherichia coli O32:H37 strain P4.

Authors:  Shlomo Blum; Noa Sela; Elimelech D Heller; Shlomo Sela; Gabriel Leitner
Journal:  J Bacteriol       Date:  2012-07       Impact factor: 3.490

3.  Fatal mastitis of dairy cows: a retrospective study.

Authors:  M J Hazlett; P B Little; M G Maxie; D A Barnum
Journal:  Can J Comp Med       Date:  1984-04

4.  Escherichia coli and Staphylococcus aureus elicit differential innate immune responses following intramammary infection.

Authors:  Douglas D Bannerman; Max J Paape; Jai-Wei Lee; Xin Zhao; Jayne C Hope; Pascal Rainard
Journal:  Clin Diagn Lab Immunol       Date:  2004-05

5.  Beta-hydroxybutyrate abrogates formation of bovine neutrophil extracellular traps and bactericidal activity against mammary pathogenic Escherichia coli.

Authors:  Navit Grinberg; Sharon Elazar; Ilan Rosenshine; Nahum Y Shpigel
Journal:  Infect Immun       Date:  2008-04-14       Impact factor: 3.441

6.  Recombinant soluble CD14 reduces severity of intramammary infection by Escherichia coli.

Authors:  Jai-Wei Lee; Max J Paape; Theodore H Elsasser; Xin Zhao
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

7.  Investigating the contribution of IL-17A and IL-17F to the host response during Escherichia coli mastitis.

Authors:  Perrine Roussel; Patricia Cunha; Adeline Porcherie; Wolfram Petzl; Florence B Gilbert; Céline Riollet; Holm Zerbe; Pascal Rainard; Pierre Germon
Journal:  Vet Res       Date:  2015-06-11       Impact factor: 3.683

8.  Genomic and Phenomic Study of Mammary Pathogenic Escherichia coli.

Authors:  Shlomo E Blum; Elimelech D Heller; Shlomo Sela; Daniel Elad; Nir Edery; Gabriel Leitner
Journal:  PLoS One       Date:  2015-09-01       Impact factor: 3.240

9.  Genomic Comparative Study of Bovine Mastitis Escherichia coli.

Authors:  Florent Kempf; Cindy Slugocki; Shlomo E Blum; Gabriel Leitner; Pierre Germon
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

10.  Escherichia coli mastitis strains: In vitro phenotypes and severity of infection in vivo.

Authors:  Perrine Roussel; Adeline Porcherie; Maryline Répérant-Ferter; Patricia Cunha; Christophe Gitton; Pascal Rainard; Pierre Germon
Journal:  PLoS One       Date:  2017-07-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.